Soy isoflavone intake and the likelihood of ever becoming a mother: the Adventist Health Study-2 by Jacobsen, Bjarne Koster et al.
© 2014 Jacobsen et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
International Journal of Women’s Health 2014:6 377–384
International Journal of Women’s Health Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
377
O r I g I n a l  r e s e a r c H
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/IJWH.S57137
Soy isoflavone intake and the likelihood of ever 







1Department of community  
Medicine, University of Tromsø, 
Tromsø, norway; 2Department  
of epidemiology, Biostatistics  
and Population Medicine, school  
of Public Health, loma linda  
University, loma linda, ca, Usa
correspondence: Bjarne K Jacobsen 
Department of community Medicine, 
Faculty of Health sciences, University of 
Tromsø, MH-building, n-9037 Tromsø, 
norway 
Tel +47 77 64 48 33 
Fax +47 77 64 48 31 
email bjarne.jacobsen@uit.no
Objectives: As little is known about the possible relationship between the intake of phyto­
estrogens and female fertility, we investigated the relationship between soy isoflavone intake 
and the risk of nulliparity and nulligravidity.
Methods: A cross­sectional study of 11,688 North American Adventist women aged 30–50 years 
old with data regarding childbearing. These women were, as a group, characterized by a high 
proportion (54%) of vegetarians and a healthy lifestyle with a very low prevalence of smoking 
and alcohol use.
Results: The mean isoflavone intake (17.9 mg per day) was very high compared to other Western 
populations. Only 6% of the women indicated no intake of isoflavones. We found, after adjustment 
for age, marital status, and educational level, an inverse relationship (P=0.05) between isoflavone 
intake and the likelihood of ever having become a mother. In women with high ($40 mg/day) 
isoflavone intake (12% of this group of women), the adjusted lifetime probability of giving 
birth to a live child was reduced by approximately 3% (95% CI: 0, 7) compared to women with 
low (,10 mg/day) intake. No relationships were found between the isoflavone intake and par­
ity or age at first delivery in parous women. A similar inverse relationship (P=0.03) was found 
between the isoflavone intake and the risk of nulligravidity with a 13% (95% CI: 2, 26) higher 
risk of never have been pregnant in women with high ($40 mg/day) isoflavone intake. These 
relationships were found mainly in women who reported problems becoming pregnant.
Conclusion: The findings suggest that a high dietary isoflavone intake may have significant 
impact on fertility.
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Introduction
Soy products are often considered a healthy alternative to meat. Some studies suggest 
that phytoestrogen isoflavones in the diet (for which soy products are the major source) 
have beneficial effects on cardiovascular diseases, osteoporosis, cancer, and  menopausal 
complaints such as hot flushes;1 however, at present no beneficial or harmful effects 
associated with isoflavones in the diet have been clearly established.2,3 The three major 
isoflavones in soy products are the glycosides daidzin, genistin, and glycitin.4
Isoflavone intake is much higher in Asian cultures (typically ~40 mg/day in older 
adults in Japan and the People’s Republic of China) than in most Western populations 
(typically ,3 mg/day).5 The mean intake in postmenopausal women in the Framing­
ham study was estimated to be only 154 µg/day6; an even lower value (59 µg/day) was 
recently reported for women of reproductive age in the US.7
Isoflavones bind to and activate estrogen receptors and there is a large amount of 
literature concerning possible reproductive effects of isoflavones in animal models;8 





isoflavones in large doses have been found to hamper fertility 
in animals.9 There has also been some interest concerning 
the impact of isoflavones on reproductive health in humans. 
These include possible short­ and long­term effects of the 
extremely high blood concentration of isoflavones in infants 
fed soy­based formula.10
There is little evidence from clinical studies of humans 
that soy protein and isoflavones have a major effect on sex 
hormone concentrations in women, although data from 
premenopausal women have indicated reduced follicle 
stimulating hormone and luteinizing hormone, and increased 
cycle length in women exposed to soy isoflavones.11 Results 
regarding soy consumption and age at puberty in girls differ 
between studies.12
A meta­analysis of 92 randomized trials did not reveal 
more side effects (including gynecological problems) in 
women who received phytoestrogens compared to those in 
a control group.13 There are a few reports of patients with 
extremely high consumption of soy products and significant 
nonmalignant uterine pathology.14,15 Lower, but still quite high 
isoflavone doses (150 mg of isoflavones per day), during a 
5­year period have been found to increase endometrial hyper­
plasia;16 an informal review indicated that more than 70 mg 
of isoflavones per day may be associated with endometrial 
bleeding in postmenopausal women.17 However, there is no 
evidence for a higher risk of endometrial cancer in women 
with a high dietary soy intake.18,19
There are some indications that supplementing with high 
doses (1,500 mg daily) of soy isoflavones may be benefi­
cial in in vitro fertilization treatment,20 but there is a need 
for studies looking at the relationship between dietary soy 
isoflavone intake and nulliparity or null gravidity within a 
diverse population.
The aim of this study was therefore to study the relation­
ships between the intake of soy isoflavones and the likelihood 
of ever becoming pregnant and delivering at least one live 
child. This was investigated in a population with a relatively 
high proportion of strict vegetarians (vegans) as well as 
subjects who were nonvegetarian. The population has, in a 
Western context, a very high consumption of soy isoflavones 
and is also characterized by a large variation in intake.
Material and methods
Adventist church members living in the USA and Canada, 
aged 30 years and older, were included in the Adventist 
Health Study­2 (AHS­2) from 2002 to 2007. More than 
96,000 participants completed a lifestyle questionnaire. 
The Adventist church encourages a healthy lifestyle with no 
smoking and alcohol consumption and advises members to 
follow a vegetarian diet.21
The comprehensive self­administered questionnaire 
included sections for marital status, ethnic group, medical 
history, smoking history, present and past use of alcohol, 
physical activity, diet (food frequency), supplement use, and 
vegetarian food consumption.
The female history section included information about, 
among other things, menarche, menstruation (including 
irregularities), difficulties in becoming pregnant (1 straight 
year or more without success to become pregnant), whether 
the women had ever been pregnant and the outcome of the 
pregnancies (miscarriages or stillbirths, ectopic pregnancies, 
elective abortion, live births), age at each delivery of a live 
child, and the use of oral contraceptives. There were also 
questions about current weight and height, as well as weight 
when aged 20.22,23 Body mass index (BMI) was computed 
as weight in kilograms divided by the square of height in 
meters (kg/m2).
assessment of diet, vegetarian status,  
and the intake of soy isoflavones
The food frequency questionnaire (FFQ) was validated 
against six 24­hour dietary recalls for intake of nutrients24 
and selected foods and food groups.25 In the present study, 
dietary intake was assessed from FFQ data. Vegetarian 
 status was determined according to the reported intake 
of foods of animal origin. Nonvegetarians ate non­fish 
meats at least once per month and all meats combined 
(fish included) more than once per week with no restric­
tions on dairy. Vegans, who constituted a subgroup of the 
 vegetarians, ate all types of meat, fish/eggs and dairy less 
than once per month.26
The FFQ includes several items to assess soy intake: 
34 commercially prepared vegetarian meat analogs; 15 soy 
beverages; and one tofu/soybean product. Isoflavone content 
was based on the Nutrition Data System for Research 2008 
database (The Nutrition Coordinating Center,  Minneapolis, 
MN, USA), an analytic database of over 20,000 foods 
updated annually while maintaining nutrient composition 
true to the version at data collection.27 Recipes were created 
for foods not in the Nutrition Data System database, such 
as homemade vegetarian dishes, soy milk, and commercial 
meat analogs. Nutrient information pertaining to such foods 
was obtained from the US Department of Agriculture, 
 manufacturers, and other published data.
The intake (I) of soy isoflavones daidzein, genistein, and 
glyceitin (in aglycone equivalent weights) was computed 
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using the product–sum method.28 Thus, I =  sum 
(weighted frequency of use of a food × weighted portion 
size consumed of that food × amount of isoflavone in a 
standard serving size of that food). The intake of vegetarian 
meat analogs, tofu/soybean products, and soy milk were 
computed the same way. Intake of soy protein according to 
the FFQ was highly correlated (r=0.8) to the intake according 
to six 24­hour dietary recalls and was also correlated (r=0.5) 
to the total isoflavonoids in urine.29
analytical cohorts
Two subgroups of women from the AHS­2 study  population 
were included in the present analyses. In addition to 
 information about isoflavone intake, we required both groups 
to provide information about marital status, level of education, 
parity, age at first delivery (if parous), and that they had also 
identified as Adventists when they were 15–25­years­old.
The first group of women included the 4,476 youngest 
women in the AHS­2 population – women aged 30–40 years 
at enrollment. As women aged 30–40 are still of childbear­
ing age, data from this group of women do not represent the 
total reproductive history of the women. Therefore, in order 
to evaluate the relationships between isoflavone intake and 
childbearing when the childbearing period for all practical 
purposes had ended, we also selected a second group of 7,212 
women aged 41–50 years. Less than 0.5% of the women in 
the AHS­2 population stated that their first birth was at age 
41 or later. The age was capped at 50 years to minimize time 
lapses between dietary habits at study baseline and those 
during childbearing years.
statistical analyses
The statistical analyses included simple cross­tabulations, 
analyses of variance, and correlation, as well as Cox 
 regression and a log­binomial model. Isoflavone intake was 
categorized into six groups (0–9, 10–19, 20–29, 30–39, 
40–49, and 50 mg or more per day).
Cox regression analyses were performed when ana­
lyzing data from women aged 30–40 years. We applied a 
 Cox­regression model with age as the time variable starting 
at age 14 (as this was the lowest age at first delivery  registered 
in the cohort); we then “followed” this retrospective cohort 
till age at enrollment in the AHS­2, using historical data. 
Interaction terms between all independent variables and 
age were included due to violation of the proportional 
hazard assumption. A woman was considered a “case” at 
the age when she had her first live child; women who were 
 nulliparous at enrollment in AHS­2 were censored at the 
age when they enrolled. Adjustments were made for marital 
status (ever married) and educational level (with or without 
a college degree). Based on this statistical model, we esti­
mated the hazard ratio (HR) for being parous according to 
the isoflavone intake categories.
When analyzing data from women aged 41–50 who 
had ended their childbearing, marital status (four groups) 
and  educational level (seven levels) were considered as 
 confounders. A log­binomial model was applied30 to esti­
mate the relative risk of ever having given birth to a child or 
never having been pregnant relative to that in women with, 
in this population, relatively low (,10 mg/day) intake of 
isoflavones. Stratified analyses within large subsets of the 
women (eg, never and ever married women, women who 
never had used alcohol or tobacco, being a vegetarian, or 
reported problems becoming pregnant) were performed.
The P-values are for the test of linear trend over the iso­
flavone intake categories, scoring from zero to five accord­
ing to increasing isoflavone intake. Ninety­five percent 
confidence intervals (CI) for HRs and relative risk estimates 
were  computed. The analyses were performed using SAS 9.3 
software (SAS Institute Inc., Cary, NC, USA).31
Results
In the group of women aged 30–50 years (including women 
from both analytical cohorts), the mean age (standard 
deviation [SD]) of the women when completing the ques­
tionnaire was 42.0 (5.4) years old. Approximately 12% of 
the women had never been married. The level of education 
was high; 51% had a college degree. Blacks constituted 
34% of the population. The large majority (75%) had used 
oral contraceptives for at least a short period of time. Mean 
age (SD) at menarche was 12.4 (1.5) years. Approximately 
74% had given birth to a live child (81% of ever married 
and 18% of never married women), and the mean (SD) 
number of  children in the 8,695 parous women was 2.2 
(0.9) and the mean age at first delivery was 26.1 (5.2) years. 
 Approximately 26%, 36%, 27%, and 11% of the parous 
women had their first delivery when they were aged ,23, 
23–27, 28–32, and .32, respectively.
Approximately 54% of the women were vegetarians 
and 7% were vegans. The mean intakes in all women of 
vegetarian meat analogs (not all soy based), soy milk, and 
tofu/other soybean products were high (51, 81, and 18 g per 
day, respectively). This was reflected in a high intake of soy 
isoflavones; the mean, median, and interquartile range were 
17.9 mg, 9.1 mg, and 21.8 mg per day, respectively. Only 6% 
of the women indicated no intake of soy isoflavones.





Table 1 gives the unadjusted relationships between some 
variables relevant in reproduction and isoflavone intake 
in all women (ie, aged 30–50 years). Women with higher 
soy isoflavone intakes were more likely to have a college 
degree and to be nulliparous or never have been pregnant, 
but were the least likely to have used oral contraceptives 
or used oral contraceptives for most of their reproduc­
tive life (for 7 or more years both when aged 20–29 and 
30–39 years). There was no relationship between isoflavone 
intake and age at menarche and the proportion of the women 
who reported problems becoming pregnant. We found a 
statistically significant inverse relationship with parity in 
all women, but not in parous women. Parous women with 
high isoflavone intake ($50 mg isoflavones/day) reported 
their first delivery approximately 1 year and 4 months later 
than parous women with low (,10 mg isoflavones/day) 
intake. Thus, the unadjusted results indicate that women 
with a high isoflavone intake more often report never hav­
ing been pregnant and being nulliparous and, if parous, 
had their first delivery  relatively late. The relationship 
with relatively late delivery was explained by education 
and marital status, however.
The prevalence of ever having been a smoker was low 
in all groups. The isoflavone intake was inversely related 
to alcohol intake. A total of 33% of the women reported 
that they had ever used alcohol, and among these women 
approximately 50% reported use for 5 years or less and with 
a very low consumption. Nearly half of those who had ever 
used alcohol stated that they had consumed beer less than 
monthly; the frequency of wine or liquor consumption was, 
if anything, even lower. Physical activity was directly related 
and BMI at age 20 years as well as the frequency of use of 
caffeinated beverages were inversely related to isoflavone 
intake. The relationship with BMI at age 20 years was weak, 
however.
The proportion of vegetarians was much higher (approxi­
mately 77%) in women with an intake of $30 mg isoflavones/
day compared to a relatively low intake (,10 mg/day) 
(approximately 38%), and the relationship between isofla­
vone intake and vegan food pattern was very strong. The 
Table 1 Relationships between soy isoflavone intake and some variables relevant to isoflavone intake and reproduction in the Adventist 
Health study-2
Soy isoflavone intake (mg per day) P for  
trend0–9 10–19 20–29 30–39 40–49 $50
number of women 6,089 1,968 1,376 812 529 914 –
Isoflavone intake (mg/day) 3.7 (2.9) 14.7 (3.1) 24.6 (2.9) 34.5 (2.9) 44.8 (2.9) 79.3 (32.5) –
age at enrollment 42.0 (5.3) 42.1 (5.3) 41.9 (5.4) 42.0 (5.4) 41.8 (5.3) 41.6 (5.6) 0.04
% never married 13.1 (798) 10.9 (215) 11.9 (164) 10.3 (84) 11.5 (61) 14.2 (130) 0.6
% with college 46.5 (2,833) 54.5 (1,072) 56.8 (781) 55.4 (450) 56.3 (298) 59.2 (541) ,0.001
% Black 35.3 (2,134) 32.8 (640) 29.5 (402) 28.0 (226) 33.9 (178) 37.4 (338) 0.2
age at menarche 12.41 (1.54) 12.37 (1.49) 12.39 (1.51) 12.49 (1.52) 12.46 (1.51) 12.40 (1.53) 0.6
% used Ocs 77.3 (4,694) 76.6 (1,502) 74.8 (1,023) 70.7 (571) 69.8 (368) 65.9 (599) ,0.001
% extended Oc use* 3.4 (206) 2.0 (39) 1.5 (20) 1.6 (13) 1.1 (6) 1.0 (9) ,0.001
% never pregnant 17.9 (1,089) 19.6 (385) 18.8 (258) 20.3 (165) 19.1 (101) 22.3 (204) 0.002
% nulliparous 24.7 (1,506) 25.7 (506) 25.9 (357) 26.5 (215) 26.1 (138) 29.7 (271) 0.003
% problems becoming pregnant 17.1 (1,032) 16.1 (315) 17.8 (243) 16.4 (132) 15.7 (82) 15.6 (141) 0.3
Parity in all women 1.69 (1.27) 1.67 (1.29) 1.60 (1.21) 1.67 (1.31) 1.61 (1.25) 1.54 (1.27) ,0.001
Parity in parous women 2.24 (0.95) 2.24 (0.97) 2.17 (0.87) 2.27 (0.97) 2.18 (0.95) 2.19 (0.93) 0.09
Age at first delivery 25.7 (5.2) 26.3 (4.9) 26.5 (5.0) 26.5 (5.0) 26.8 (5.2) 27.0 (5.3) ,0.001
% ever smoked  7.0 (426) 4.6 (91) 4.7 (65) 3.7 (30) 4.9 (26) 4.3 (39) ,0.001
% ever used alcohol 38.4 (2,327) 27.1 (533) 27.6 (379) 26.6 (216) 28.0 (148) 25.9 (235) ,0.001
Physical activity (times/week) 2.2 (1.9) 2.4 (1.9) 2.5 (1.9) 2.7 (1.9) 2.6 (1.9) 2.6 (1.9) ,0.001
BMI (kg/m2) at age 20 21.6 (3.8) 21.3 (3.4) 21.4 (3.6) 21.3 (3.7) 21.3 (3.7) 21.4 (4.1) 0.002
% with monthly use of caffeinated drinks 49.3 (2,956) 32.8 (633) 27.6 (375) 21.7 (173) 19.8 (102) 17.5 (157) ,0.001
% vegetarians 37.6 (2,292) 63.6 (1,252) 71.6 (985) 77.7 (631) 76.6 (405) 76.5 (699) ,0.001
% vegans 2.1 (125) 7.0 (137) 10.7 (147) 15.4 (125) 17.8 (94) 18.7 (171) ,0.001
Vegetarian meat analogs (g/day) 37 (38) 62 (56) 66 (64) 66 (58) 69 (73) 81 (81) ,0.001
Tofu/soybean products (g/day) 3 (4) 12 (12) 24 (19) 38 (23) 49 (30) 91 (74) ,0.001
Soy milk (g/day) 9 (29) 74 (79) 120 (112) 153 (139) 210 (171) 380 (333) ,0.001
Energy intake (kcal per day) 1,736 (702) 1,890 (689) 1,980 (687) 2,090 (702) 2,267 (721) 2,506 (788) ,0.001
Notes: *Used OCs for 7 or more years both when aged 20–29 years and when aged 30–39 years. Data given as percentages (n) or mean (SD).
Abbreviations: sD, standard deviation; Oc, oral contraceptives; BMI, body mass index.




Isoflavone intake and nulliparity and nulligravidity
Spearman’s  correlation coefficients between soy isoflavone 
intake  (categorized in Table 1) and being vegetarian or vegan 
were 0.34 and 0.23, respectively. The correlation coefficient 
between soy isoflavone intake (categorized as in Table 1) 
and the intake of soy milk was 0.70, with tofu/other soybean 
products 0.71, and with the intake of vegetarian meat analogs 
(not all soy based) 0.29. There was a positive relationship 
between the isoflavone intake and the energy intake.
Analyses restricted to the 4,476 women who were aged 
30–40 years at enrollment and adjusted for marital status 
(ever/never married) and level of education demonstrated 
an inverse relationship between isoflavone intake and the 
probability of never giving birth to a live child. However, the 
association was clearly attenuated by attained age (stronger 
relationship in younger women). Thus, we present the esti­
mated HRs at age 26 years, the mean age at first delivery in 
parous women (Table 2). A statistically significant (P=0.003) 
inverse relationship was found. Further analyses (not shown) 
indicated that the relationship was statistically significant 
(P#0.05) at all ages below 28. Adjustments for race, ever 
use of oral contraceptives, body mass at age 20 years, or 
restricting the analyses to ever married women (n=3,681) 
only marginally influenced the results displayed in Table 2. If 
anything, the relationships were strengthened when adjusted 
for the energy intake or restricted to women who never had 
used alcohol or tobacco. When stratified for being a vegetar­
ian or not, the linear relationship was, however, only found in 
nonvegetarians. Although statistically significant (P,0.05) in 
both women who did not report problems becoming pregnant 
and women who reported such problems, the relationship 
was stronger in the latter group of women (P­value for 
interaction =0.08).
Table 3 gives the results from the analyses including the 
7,212 women aged 41–50 years, women who for all practical 
purposes have ended their childbearing period. A total of 78% 
of these women were parous. A linear inverse relationship 
(P=0.05) was seen between isoflavone intake and the prob­
ability of giving birth to at least one child with 1% reduced 
risk per unit (basically 10 mg per day) increase in isoflavone 
intake. Women who had a high ($40 mg/day) intake had a 
3% (95% CI: 0, 7) lower risk of being parous than women 
with a low (,10 mg/day) isoflavone intake.
The associations were found in both ever and never 
married women. Adjustment for race, use of oral contracep­
tives, physical activity, BMI at age 20 years, monthly or 
more frequent use of caffeinated beverages, and ever hav­
ing smoked or used alcohol in concert did not change the 
findings more than marginally. The relationship between the 
isoflavone intake and nulliparity was, if anything, stronger 
in the 4,884 women who never had used alcohol or tobacco 
(P=0.01). Adjustments for vegetarianism tended to somewhat 
strengthen the association, and there was no interaction 
with being a vegetarian. The relationship was statistically 
significant in women who reported problems in becoming 
pregnant, whereas essentially no relationship was found in 
other women; a formal test for interaction was statistically 
significant (P=0.01). In women who reported problems 
becoming pregnant, a one unit (10 mg per day) increase in 
isoflavone intake was associated with a 4% (95% CI: 1, 6) 
higher nulliparity risk.
The mean (SD) parity and age at first delivery in parous 
women was 2.3 (0.9) children and 26.1 (5.2) years, respec­
tively, among women aged 41–50 years. The isoflavone 
intake, after adjustments for age, education and marital status, 
Table 2 Associations between soy isoflavone intake (mg per day) 
and fertility (at least one live child) estimated at age 26 years in 
the adventist Health study-2
Isoflavone intake  
(mg/day)
Number of women/ 
parous women
Hazard ratio 
(95% CI)  
at age 26 years
,10 2,281/1,569 1.0
10–19 742/512 0.92 (0.83, 1.02)
20–29 526/358 0.93 (0.84, 1.04)
30–39 320/220 0.86 (0.74, 1.00)
40–49 221/152 0.93 (0.78, 1.10)
50+ 386/259 0.83 (0.72, 0.96)
all 4,476/3,070
P-value for linear trend 0.003
Notes: adjusted for educational level and marital status. Women aged 30–40 years 
when completing the lifestyle questionnaire.
Abbreviation: CI, confidence interval.
Table 3 Associations between soy isoflavone intake (mg per day) 
and fertility (at least one live child) in the Adventist Health Study-2
Isoflavone intake  
(mg/day)




risk (95% CI) for  
giving birth to at  
least one live child
,10 3,808/3,014 1.0
10–19 1,226/950 0.99 (0.96, 1.02)
20–29 850/661 0.99 (0.96, 1.02)
30–39 492/377 0.97 (0.93, 1.02)
40–49 308/239 0.98 (0.93, 1.03)
50+ 528/384 0.96 (0.92, 1.01)
all 7,212/5,625
P-value for linear trend 0.05
Notes: adjusted for age when completing the lifestyle questionnaire, educational 
level and marital status. Women aged 41–50 years when completing the lifestyle 
questionnaire.
Abbreviation: CI, confidence interval.





was not associated with parity or age at first delivery when 
the analysis was confined to parous women.
In accordance with the findings for nulliparity, we also 
observed a linear direct relationship (P=0.03) between the 
isoflavone intake and never having been pregnant (Table 4). 
Women who had a relatively high intake (40 mg isoflavone 
per day or above) had an approximately 13% (95% CI: 2, 26) 
higher risk of never having been pregnant than women with a 
relatively low intake (,10 mg/day). In contrast to the findings 
for nulliparity, adjustments for being a vegetarian reduced 
the strength of the relationship and it was not statistically 
significant after adjustments. There was no interaction with 
being a vegetarian, however.
Similarly to the relationships with nulliparity, we found 
indications of a stronger relationship in women who reported 
problems becoming pregnant than in other women (P­value 
for interaction =0.08). In the former group of women, a statis­
tically significant (P=0.01) positive relationship between the 
isoflavone intake and never having been pregnant was found, 
with a 9% (95% CI: 2, 17) increased risk per unit (10 mg 
per day) increase in isoflavone intake. In women who did not 
report problems becoming pregnant, a weaker relationship 
(P=0.06) was found, with a 2% (95% CI: 0, 5) increased risk 
per unit (10 mg per day) increase in isoflavone intake.
Discussion
The main finding of this study is that women who in a Western 
context have a very high isoflavone intake have a somewhat 
increased risk of never having been pregnant or given birth 
to a live child. The results suggest that when the isoflavone 
intake exceeds approximately 40 mg per day, the overall 
lifetime risk of never becoming pregnant increased by 13% 
and that of ever giving birth to a live child was reduced by 
approximately 3%. The associations were consistently found 
to be stronger in women who reported having had difficulties 
in becoming pregnant (1 straight year or more without suc­
cess to become pregnant). To our knowledge, this is the first 
study which has examined the possible relationship between 
isoflavone intake and fertility within a diverse, non­clinical, 
population.
One major limitation in our study is that we are not able 
to distinguish with certainty between involuntary and vol­
untary childlessness. Both may be related to the isoflavone 
intake. If high isoflavone intake increases the risk of longer 
cycle length11 and/or uterine pathology (fibroids, endometrial 
growth, etc),14–16 this may hamper fertility. It is also possible 
that women who differ with regard to the isoflavone intake 
also differ with regard to other lifestyle and sociological 
factors related to childbearing other than those that we have 
been able to adjust for. The stronger relationship between 
isoflavone intake and the proportion who report to be nul­
liparous or never having been pregnant in women who had 
problems becoming pregnant does, however, suggest a 
biological impact of isoflavones.
The isoflavone intake (mean intake 17.9 mg/day) 
was very high compared to other Western populations 
 (typically ,3 mg/day).5 The large intake and large varia­
tion in intake in our study made it possible to examine the 
impact of high intake of isoflavones on childbearing. The 
intake of isoflavones was based on information about current 
food habits. As discussed elsewhere,29 there are consider­
able uncertainties related to the isoflavone content of the 
foods. This misclassification will, however, be unrelated to 
 nulliparity; it has introduced non­differential misclassifica­
tion and thus attenuated the associations.
Another limitation is that for many women there may be 
several years between age at first delivery and completing the 
questionnaire; misclassification with regard to dietary intake 
before and during childbearing has therefore undoubtedly 
taken place. However, the women included were all current 
members of the Adventist church who also indicated that 
they had been Adventists when they were 15–25­years­old. 
Therefore, the majority of them have probably not made 
dramatic changes in their lifestyle – including dietary  habits – 
during the childbearing years. An indication of adherence to 
this lifestyle is that only 6% of the women had ever smoked 
cigarettes.
Unpublished observations, based on a retrospective 
enquiry relating to the past decade of life, indicate a ten­
dency in this Adventist population to change their dietary 
Table 4 Associations between soy isoflavone intake (mg per day) 
and never having been pregnant in the adventist Health study-2
Isoflavone intake  
(mg/day)
Number of women/ 
never pregnant  
women
Estimated relative 
risk (95% CI)  
for never been  
pregnant
,10 3,808/558 1.0
10–19 1,226/208 1.14 (1.03, 1.26)
20–29 850/129 0.98 (0.86, 1.12)
30–39 492/85 1.10 (0.95, 1.27)
40–49 308/52 1.11 (0.92, 1.33)
50+ 528/103 1.15 (1.02, 1.29)
all 7,212/1,135
P-value for linear trend 0.03
Notes: adjusted for age when completing the lifestyle questionnaire, educational 
level, and marital status. Women aged 41–50 when completing the lifestyle 
questionnaire.
Abbreviation: CI, confidence interval.
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 habits in a vegetarian direction (and thus increasing iso­
flavone intake) with advancing age. However, only a very 
weak (and  actually inverse) cross­sectional relationship was 
found between the isoflavone intake and age in our study 
sample. A direct relationship between isoflavone intake and 
nulliparity will be found if nulliparous women increased 
the intake of soy products and isoflavone to a greater degree 
than parous women, eg, that women with problems becom­
ing pregnant increased their intake of soy product because 
they believed that these products would enhance fertility. 
We have no indications that this has been the case as there 
were no relationships between the isoflavone intake and 
the proportion who reported problems becoming pregnant 
(Table 1). This was the case in both women aged 30–40 and 
those aged 41–50 years.
In order to address the problem of the time lag between 
childbearing and the reported dietary habits, we investi­
gated the relationship in two different groups of women, 
30–40­year­olds and 41–50­year­olds. In women aged 
30–40 years, the mean duration between the first delivery 
and completion of the questionnaire was approximately 
10 years.  However, women may still give birth to their first 
child at later ages. Therefore, we also included a group of 
women aged 41–50 years who for all practical purposes have 
ended their childbearing when completing the questionnaire. 
For these women, the time period between childbearing 
and information on dietary habits may have been quite long 
(a mean of approximately 20 years). However, results from 
both analytical cohorts indicated that a high isoflavone intake 
increased the likelihood of nulliparity.
The HRs given in Table 2 are estimated from the Cox 
regression model, essentially following the women from 
the age of 14 years (as detailed in the Material and methods 
 section). Thus, there is no contradiction in estimating the HRs 
(eg, at age 26 years) even though no women were below age 
30 years at enrollment.
We consider it a strength of this study that it is conducted in 
a population with extensive information on dietary habits and 
where the possible impact of alcohol and smoking can be virtu­
ally excluded. Alcohol and caffeine consumption have been 
studied in relation to possible impact on fertility (with mixed 
results).32–34 Smoking reduces fertility and has, as it is well 
known, a number of adverse effects on pregnancy outcomes.35 
The women included in our study had very low prevalence of 
ever smoking (6%) and also a low consumption of alcohol; 
only 33% of the women had ever used alcohol and the alcohol 
intake among most of the ever­users was negligible during the 
years they did use alcohol (less than monthly).
Women who differ with regard to diet also may differ 
with regard to the other variables known to have an impact 
on childbearing. We adjusted for not only the most important 
predictors for childbearing, in particular marital status and 
educational level, but also for race (Black versus non­Black), 
use of oral contraceptives, BMI at age 20 years,22,23 physical 
activity, and monthly or more frequent use of caffeinated 
beverages, in separate analyses. Furthermore, stratified analy­
ses including only women who had never smoked  cigarettes 
or used alcohol confirmed our findings from analyses in all 
women. One possible unmeasured confounder is the male 
partner’s diet. If male diet influences fertility, this may have 
had an impact on the associations as the spouses often con­
form to the same dietary pattern.
The results of the analyses based on the two populations 
aged 30–40 and 41–50 years, respectively, seem only to 
 differ significantly at one point, ie, with regard to a possible 
interaction with being a vegetarian. However interesting, 
we have no obvious explanation for the seemingly differ­
ent results; given the somewhat exploratory nature of our 
analyses and the many statistical tests conducted, we do 
not believe that this apparent inconsistency deserves much 
emphasis at this point.
Conclusion
In summary, we find that women with a high intake of iso­
flavones have an increased risk of never becoming pregnant 
and being childless when they are at an age where they are at 
the end of their childbearing period (aged 41–50 years). Both 
sociological and biological explanations may be put forward 
to explain our findings. The stronger relationship in women 
who reported problems becoming pregnant is, in this context, 
interesting. However, we call for further studies, preferably 
prospective studies, to either refute or confirm our findings 
that isoflavones have a significant impact on childbearing.
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